Company / Working Capital
McKesson Corporation Working Capital History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
-$9.8B
FY2026
5-year range
-$9.8B / -$2.2B
FY2022-FY2026
Trend
-58.0%
vs FY2025
Sector context
#158 of 160
Health Care
What the data says
Among 160 Health Care companies, McKesson Corporation is in the bottom 1% for working capital. Working Capital has declined for 5 consecutive years, from $1.3B in FY2021 to -$9.8B in FY2026.
Based on SEC 10-K filings.
-$9.8B in FY2026.
Declined from -$4.4B to -$9.8B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 160This company -$9.8B Sector average $757.1M
▼
-1395.4% below sector average
Key checks
Key Insights
- McKesson Corporation's working capital has declined for 5 consecutive years.
- In FY2026, working capital decreased 58.0% year-over-year.
- Ranks #158 out of 160 companies in the Health Care sector.
- Peak working capital was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | -$9.8B | -58.0% |
| FY2025 | -$6.2B | -41.5% |
| FY2024 | -$4.4B | -19.7% |
| FY2023 | -$3.7B | -64.0% |
| FY2022 | -$2.2B | -274.7% |
| FY2021 | $1.3B | +418.2% |
| FY2020 | -$402.0M | -147.9% |
| FY2019 | $839.0M | +86.0% |
| FY2018 | $451.0M | -66.2% |
| FY2017 | $1.3B | -60.3% |
As of FY2026 · SEC 10-K · Updated Jul 4, 2026